{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:50:14Z","timestamp":1794948614665,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012358","name":"Resuscitation Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.waojou.2021.100517","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T13:29:41Z","timestamp":1612531781000},"page":"100517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee"],"prefix":"10.1016","volume":"14","author":[{"given":"Paul J.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio J.","family":"Ansotegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Ebisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehia","family":"El-Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Fineman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Gonzalez-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Greenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes S.Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Muraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"S\u00e1nchez Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianenrico","family":"Senna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana K.","family":"Tanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard Yu-Hor","family":"Thong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margitta","family":"Worm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.waojou.2021.100517_bib1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults","volume":"137","author":"McNeil","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2021.100517_bib2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jaci.2018.12.1003","article-title":"Anaphylaxis after vaccination reported to the vaccine adverse event reporting system, 1990-2016","volume":"143","author":"Su","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2021.100517_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-016-0120-5","article-title":"International Consensus (ICON): allergic reactions to vaccines","volume":"9","author":"Dreskin","year":"2016","journal-title":"World Allergy Organ J"},{"issue":"7","key":"10.1016\/j.waojou.2021.100517_bib4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/pai.12762","article-title":"Vaccination and allergy: EAACI position paper, practical aspects","volume":"28","author":"Nilsson","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2021.100517_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/archdischild-2011-301163","article-title":"Anaphylaxis as an adverse event following immunisation in the UK and Ireland","volume":"97","author":"Erlewyn-Lajeunesse","year":"2012","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.waojou.2021.100517_bib6","series-title":"Presentation to ACIP COVID-19 vaccines work group December 19 2020 meeting","article-title":"Anaphylaxis following m-RNA COVID-19 vaccine receipt","author":"Clark","year":"2020"},{"key":"10.1016\/j.waojou.2021.100517_bib7","series-title":"Confirmation of Guidance to Vaccination Centres on Managing Allergic Reactions Following COVID-19 Vaccination with the Pfizer\/BioNTech Vaccine","author":"Raine","year":"2020"},{"key":"10.1016\/j.waojou.2021.100517_bib8","doi-asserted-by":"crossref","unstructured":"COVID-19 vaccine safety update. 27 January 2021., 2021. [Accessed 6 Feb 2021]","DOI":"10.26444\/monz\/143362"},{"key":"10.1016\/j.waojou.2021.100517_bib9","series-title":"Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States - Appendix B","year":"2020"},{"key":"10.1016\/j.waojou.2021.100517_bib10","series-title":"Medicines and Healthcare Products Regulatory Agency (MHRA)","year":"2020"},{"issue":"7","key":"10.1016\/j.waojou.2021.100517_bib11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/cea.12760","article-title":"Immediate-type hypersensitivity to polyethylene glycols: a review","volume":"46","author":"Wenande","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2021.100517_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2005.06.001","article-title":"Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products","volume":"214","author":"Fruijtier-Polloth","year":"2005","journal-title":"Toxicology"},{"issue":"20","key":"10.1016\/j.waojou.2021.100517_bib13","article-title":"Polyethylene glycol-induced systemic allergic reactions (anaphylaxis)","volume":"S2213\u20132198","author":"Sellaturay","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2021.100517_bib14","article-title":"Allergy to polyethylene glycol has significant impact on daily life","author":"Bruusgaard-Mouritsen","year":"2020","journal-title":"Author"},{"issue":"20","key":"10.1016\/j.waojou.2021.100517_bib15","article-title":"Anti-PEG IgE in anaphylaxis associated with polyethylene glycol","volume":"S2213\u20132198","author":"Zhou","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2021.100517_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.molimm.2008.08.276","article-title":"Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process","volume":"46","author":"Hamad","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.waojou.2021.100517_bib17","article-title":"mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and approach","author":"Banerji","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2021.100517_bib18","article-title":"Polysorbates, biotherapeutics and anaphylaxis: a review","author":"Maggio","year":"2017","journal-title":"Bioprocess Int"},{"issue":"5","key":"10.1016\/j.waojou.2021.100517_bib19","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaip.2018.12.003","article-title":"Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized","volume":"7","author":"Stone","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2021.100517_bib20","first-page":"2012","article-title":"Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80","author":"Badiu","year":"2012","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.waojou.2021.100517_bib22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.waojou.2021.100517_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/cea.12882","article-title":"Vaccination management in children and adults with mastocytosis","volume":"47","author":"Zanoni","year":"2017","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10.1016\/j.waojou.2021.100517_bib24","doi-asserted-by":"crossref","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2021.100517_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13223-016-0172-7","article-title":"Polyethylene glycol as a cause of anaphylaxis","volume":"12","author":"Wylon","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.waojou.2021.100517_bib26","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"31","key":"10.1016\/j.waojou.2021.100517_bib27","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"Ju","year":"2007","journal-title":"Vaccine"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455121000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455121000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:42:16Z","timestamp":1761849736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455121000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1939455121000119"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2021.100517","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2021.100517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100517"}}